|
|
Line 21: |
Line 21: |
|
| |
|
| ===Tests=== | | ===Tests=== |
| ====Hereditary====
| | A list of tests are found in the ''[[Molecular pathology tests]]'' article. |
| {| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
| |
| ! Target
| |
| ! Technique
| |
| ! Disease
| |
| ! Notes
| |
| |-
| |
| | F2<ref>{{OMIM|176930}}</ref>
| |
| | PCR
| |
| | thrombophilia
| |
| | see ''[[Pulmonary_embolism#Risks_factors_.28VTE.29|Risks for VTE]]''
| |
| |-
| |
| | F5<ref>{{OMIM|612309}}</ref>
| |
| | PCR
| |
| | thrombophilia
| |
| | see ''[[Pulmonary_embolism#Risks_factors_.28VTE.29|Risks for VTE]]''
| |
| |-
| |
| | HFE<ref>{{OMIM|613609}}</ref> Cys282Tyr, His63Asp
| |
| | PCR
| |
| | [[hemochromatosis]]
| |
| | -
| |
| |-
| |
| | RYR1
| |
| | PCR & sequencing
| |
| | malignant hyperthermia
| |
| | anesthetics
| |
| |-
| |
| | several
| |
| | PCR & sequencing
| |
| | herediary [[amyloidosis]]
| |
| |
| |
| |-
| |
| | HBA
| |
| | PCR
| |
| | Alpha thalassemia
| |
| |
| |
| |}
| |
| | |
| ====[[Lymphoma]]====
| |
| {| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
| |
| ! Target
| |
| ! Technique
| |
| ! Disease
| |
| ! Notes
| |
| |-
| |
| | BCL2
| |
| | PCR
| |
| | follicular lymphoma vs. follicular hyperplasia
| |
| |
| |
| |-
| |
| | several
| |
| | Southern / PCR
| |
| | T cell neoplasia
| |
| |
| |
| |-
| |
| | Ig heavy chain, Ig light chain
| |
| | Southern / PCR
| |
| | B cell neoplasia
| |
| |
| |
| |-
| |
| | EBV
| |
| |
| |
| | PTLPD vs. rejection
| |
| |
| |
| |-
| |
| | HHV8
| |
| | PCR, HPV linear array
| |
| | HHV8 associated lymphomas (body cavity lymphoma, primary effusion lymphoma)
| |
| |
| |
| |}
| |
| | |
| ====Leukemia====
| |
| *Several.
| |
| | |
| ====Carcinoma====
| |
| {| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
| |
| ! Target
| |
| ! Technique
| |
| ! Disease
| |
| ! Notes
| |
| |-
| |
| | EBV quantitation
| |
| | PQ-PCR
| |
| | [[Nasopharyngeal carcinoma]]
| |
| |
| |
| |-
| |
| | HPV several
| |
| | PCR
| |
| | squamous cell carcinoma ([[cervix]])
| |
| |
| |
| |-
| |
| | KRAS, BRAF
| |
| | fluorescent RFLP, real time PCR, sequencing
| |
| | netastatic [[colorectal carinoma]]
| |
| |
| |
| |-
| |
| | EGRF
| |
| | fluorescent RFLP
| |
| | non small cell [[lung cancer]]
| |
| |
| |
| |-
| |
| | BRAF V600E
| |
| | ARMS
| |
| | [[papillary thyroid carcinoma]]
| |
| |
| |
| |}
| |
| | |
| ====Other====
| |
| {| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
| |
| ! Target
| |
| ! Technique
| |
| ! Disease
| |
| ! Notes
| |
| |-
| |
| | LOH 1p, 19q
| |
| | PCR
| |
| | [[oligodendroglioma]]
| |
| |
| |
| |-
| |
| |
| |
| | 15 STRs and amelogenin (XY) loci
| |
| | identity testing
| |
| |
| |
| |-
| |
| | KIT, BRAF
| |
| | sequencying, ARMS
| |
| | [[malignant melanoma]]
| |
| |
| |
| |-
| |
| | several
| |
| | PQ-PCR
| |
| | [[synovial sarcoma]]
| |
| |
| |
| |-
| |
| | JAK2 V617F
| |
| | ARMS
| |
| | myeloproliferative disorders
| |
| |
| |
| |-
| |
| | KIT
| |
| | sequencing
| |
| | AML, mastocytosis, [[GIST]]
| |
| |
| |
| |}
| |
|
| |
|
| ==Cytogenetics== | | ==Cytogenetics== |